Assert-IQ vs Cardiomo
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your healthcare system requires a long-term, highly reliable, and minimally invasive solution for continuous cardiac monitoring in patients with suspected heart rhythm disorders. This tool is ideal for comprehensive arrhythmia detection and management within a clinical setting, offering robust data for physician diagnosis and treatment planning over several years.
View Assert-IQ →Choose Cardiomo if…
Choose Cardiomo if you need a flexible, patient-centric wearable solution for continuous remote heart health monitoring and early detection of cardiovascular events. This tool is best suited for individuals and caregivers who benefit from real-time alerts, mobile accessibility, and the convenience of a medical-grade patch for ongoing vital sign tracking in a home or outpatient setting.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieAssert-IQ is a minimally invasive insertable device, offering long-term, continuous monitoring without patient interaction after insertion, which enhances passive usability. Cardiomo is a wearable patch with a mobile app, requiring patient adherence for wearing and charging, but offering a user-friendly interface for real-time data and alerts. Both aim for ease of use in their respective contexts, making it a tie.
Clinical Value
Assert-IQAssert-IQ provides long-term continuous cardiac monitoring for up to 6 years and uses advanced AI algorithms to reduce false positives and improve accuracy in arrhythmia detection, which is crucial for clinical decision-making. Cardiomo offers continuous vital sign monitoring and AI-powered disease detection with real-time alerts, but its clinical validation and longevity are not as extensively detailed for long-term, physician-focused diagnostic use.
Pricing & Value
TieBoth tools lack transparent public pricing, making a direct comparison of value difficult. Assert-IQ is an enterprise-focused solution requiring contact with Abbott Medical for institutional pricing. Cardiomo previously offered a consumer price with a monthly subscription, but current pricing is not publicly available.
Enterprise Readiness
Assert-IQAssert-IQ is designed for large health systems, hospitals, and cardiology clinics, offering secure cloud-based data, remote monitoring, proactive clinician alerts, and remote programmability, indicating strong enterprise readiness. While Cardiomo is HIPAA-compliant and offers cloud analytics, its primary focus appears to be a B2B and B2B2C model, and its enterprise-specific features and integrations are not as clearly defined as Assert-IQ's.
Innovation
Assert-IQAssert-IQ stands out with its combination of AI algorithms, the world's longest-lasting Bluetooth-enabled ICM (up to 6 years), and IQ Insights for comprehensive cardiovascular health trends. Cardiomo utilizes AI for disease detection and offers a medical-grade wearable patch with a long battery life, but Assert-IQ's integrated AI for false positive reduction and extended monitoring duration represent a more significant leap in the ICM space.
Support & Docs
Assert-IQAbbott Medical, as a large established company, provides comprehensive support and documentation for Assert-IQ, including clinician manuals, patient guides, remote programming guides, and dedicated technical support. Cardiomo's documentation and support details are less publicly available, though it does offer a mobile application for users and alerts for caregivers.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Cardiomo |
|---|---|---|
| Name | Assert-IQ | Cardiomo |
| Company | Abbott Medical | Cardiomo, Inc. |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Mobile App | None | Android and iOS |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days) |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Cardiomo.